These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy. Avery PJ; Jorgensen A; Hamberg AK; Wadelius M; Pirmohamed M; Kamali F; Clin Pharmacol Ther; 2011 Nov; 90(5):701-6. PubMed ID: 22012312 [TBL] [Abstract][Full Text] [Related]
6. Warfarin pharmacogenetics: to genotype or not to genotype, that is the question. Cavallari LH; Nutescu EA Clin Pharmacol Ther; 2014 Jul; 96(1):22-4. PubMed ID: 24942399 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of warfarin. Kamali F; Wynne H Annu Rev Med; 2010; 61():63-75. PubMed ID: 19686083 [TBL] [Abstract][Full Text] [Related]
8. Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing. Roper N; Storer B; Bona R; Fang M J Mol Diagn; 2010 May; 12(3):283-91. PubMed ID: 20228265 [TBL] [Abstract][Full Text] [Related]
10. Warfarin pharmacogenetics: does more accurate dosing benefit patients? Eby C Semin Thromb Hemost; 2012 Oct; 38(7):661-6. PubMed ID: 23047421 [TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Gong IY; Tirona RG; Schwarz UI; Crown N; Dresser GK; Larue S; Langlois N; Lazo-Langner A; Zou G; Roden DM; Stein CM; Rodger M; Carrier M; Forgie M; Wells PS; Kim RB Blood; 2011 Sep; 118(11):3163-71. PubMed ID: 21725053 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials. Wang ZQ; Zhang R; Zhang PP; Liu XH; Sun J; Wang J; Feng XF; Lu QF; Li YG J Cardiovasc Pharmacol; 2015 Apr; 65(4):364-70. PubMed ID: 25551322 [TBL] [Abstract][Full Text] [Related]
13. Warfarin Pharmacogenetics: New Life for an Old Drug. Wen MS; Lee MT Acta Cardiol Sin; 2013 May; 29(3):235-42. PubMed ID: 27122712 [TBL] [Abstract][Full Text] [Related]
15. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future. Ndadza A; Thomford NE; Mukanganyama S; Wonkam A; Ntsekhe M; Dandara C OMICS; 2019 Mar; 23(3):152-166. PubMed ID: 30883300 [TBL] [Abstract][Full Text] [Related]
16. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study. Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428 [TBL] [Abstract][Full Text] [Related]
18. Warfarin: a case history in pharmacogenetics. Hall AM; Wilkins MR Heart; 2005 May; 91(5):563-4. PubMed ID: 15831631 [TBL] [Abstract][Full Text] [Related]
19. The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis. You JH; Chan FW; Wong RS; Cheng G Thromb Haemost; 2004 Sep; 92(3):590-7. PubMed ID: 15351856 [TBL] [Abstract][Full Text] [Related]
20. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. Gage BF; Eby C; Milligan PE; Banet GA; Duncan JR; McLeod HL Thromb Haemost; 2004 Jan; 91(1):87-94. PubMed ID: 14691573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]